EB1Homo sapiens (Human)Cancer cell line
Also known as: Epstein-Barr-1, EB-1
Quick Overview
Human B cell line from Burkitt's lymphoma, used in cancer research.
Detailed Summary
Research Applications
Key Characteristics
Basic Information
Database ID | CVCL_2027 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Bone, jaw, maxilla[UBERON:UBERON_0002397] |
Donor Information
Age | 9 |
---|---|
Age Category | Pediatric |
Sex | Female |
Race | black_or_african_american |
Disease Information
Disease | Burkitt lymphoma |
---|---|
Lineage | Lymphoid |
Subtype | Burkitt Lymphoma |
OncoTree Code | BL |
DepMap Information
Source Type | ATCC |
---|---|
Source ID | ACH-000877_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | TP53 | p.Gly244Asp (c.731G>A) | Unspecified | - | PubMed=28273451 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Sellers W.R.
Nature 569:503-508(2019).
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
Cancer Res. 79:1263-1273(2019).
Screening human cell lines for viral infections applying RNA-Seq data analysis.
Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.
PLoS ONE 14:E0210404-E0210404(2019).
Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.
Yang H.H., Koeffler H.P.
BMC Cancer 18:940.1-940.13(2018).
Characterization of human cancer cell lines by reverse-phase protein arrays.
Liang H.
Cancer Cell 31:225-239(2017).
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Loewer M., Sahin U., Castle J.C.
Genome Med. 7:118.1-118.7(2015).
A resource for cell line authentication, annotation and quality control.
Neve R.M.
Nature 520:307-311(2015).
A comprehensive transcriptional portrait of human cancer cell lines.
Settleman J., Seshagiri S., Zhang Z.-M.
Nat. Biotechnol. 33:306-312(2015).
Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Vettorazzi E., Bokemeyer C., Dierlamm J.
Genes Chromosomes Cancer 53:497-515(2014).
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
Nature 483:603-607(2012).
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.
Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.
J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010).
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Haber D.A.
Cancer Res. 70:2158-2164(2010).
Fine structural organization of human lymphoblasts of a tissue culture strain (EB1) from Burkitt's lymphoma.
Epstein M.A., Achong B.G.
J. Natl. Cancer Inst. 34:241-253(1965).
Characteristics and mode of growth of tissue culture strain (EB1) of human lymphoblasts from Burkitt's lymphoma.
Epstein M.A., Barr Y.M.
J. Natl. Cancer Inst. 34:231-240(1965).
Cultivation in vitro of human lymphoblasts from Burkitt's malignant lymphoma.
Epstein M.A., Barr Y.M.
Lancet 283:252-253(1964).
Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool.
van Dongen J.J.M.
Leukemia 16:1572-1573(2002).
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Quentmeier H., Drexler H.G.
Leukemia 10:142-149(1996).
Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
Jain V.K., Judde J.-G., Max E.E., Magrath I.T.
J. Immunol. 150:5418-5428(1993).
Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.
Povey S., Jeremiah S., Arthur E., Steel M., Klein G.
Ann. Hum. Genet. 44:119-133(1980).
Chromosome studies of 8 in vitro lines of Burkitt's lymphoma.";
Miles C.P., O'Neill F.
Cancer Res. 27:392-402(1967).
Studies with Burkitt's lymphoma.";
Epstein M.A., Barr Y.M., Achong B.G.
Wistar Inst. Symp. Monogr. 4:69-82(1965).
Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats.
McComb V.
Cancer 24:211-222(1969).
The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel C.M., Morten J.E.N., Foster E.
IARC Sci. Publ. 60:265-292(1985).